Myriad Genetics, Inc. (MYGN) vs OPKO Health, Inc. (OPK)
- Myriad Genetics, Inc. MYGN 3.98 −8.51%
- OPKO Health, Inc. OPK 1.53 −4.97%
Myriad Genetics, Inc. and OPKO Health, Inc. are both Diagnostics & Research companies. OPKO Health, Inc. is the larger, with a market value of $1.2B against $416.1M — 2.9× the size. Myriad Genetics, Inc. grew revenue faster over the last twelve months: −3.16% against −11.5%. OPKO Health, Inc. has the higher net margin (−12.4% vs −14.0%) and the higher return on invested capital (−2.45% vs −19.9%). Across the 18 metrics below, OPKO Health, Inc. leads on 10 and Myriad Genetics, Inc. on 8.
Valuation
Profitability
| Metric | MYGN | OPK | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 68.83% | 40.77% | 50.89% |
| Operating margin | (12.22%) | (8.21%) | (8.57%) |
| Net margin | (13.96%) | (12.40%) | (6.37%) |
| Free cash flow margin | (1.76%) | (22.75%) | 0.00% |
| Return on equity | (32.54%) | (5.88%) | (2.92%) |
| Return on assets | (17.11%) | (3.83%) | (6.71%) |
| Return on invested capital | (19.92%) | (2.45%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack